MOLECULAR DOCKING STUDY ON 1-(3-(4-BENZYLPIPERAZIN-1-YL)PROPYL)-3,7-DIMETHYL-1H-PURINE-2,6(3H,7H)-DIONE AS AN ACETYLCHOLINESTERASE INHIBITOR

被引：1
作者：
Hristova, Maria [1 ]
Atanasova, Mariyana [2 ]
Valkova, Iva [2 ]
Andonova, Lilya [1 ]
Doytchinova, Irini [2 ]
Zlatkov, Alexander [1 ]
机构：
[1] Med Univ Sofia, Fac Pharm, Dept Pharmaceut Chem, Sofia, Bulgaria
[2] Med Univ Sofia, Fac Pharm, Dept Chem, Sofia, Bulgaria
来源：
CBU INTERNATIONAL CONFERENCE PROCEEDINGS 2018: INNOVATIONS IN SCIENCE AND EDUCATION | 2018年 / 6卷
关键词：
acetylcholinesterase; molecular docking; AChE inhibitors; GALANTAMINE DERIVATIVES; PIPERAZINE DERIVATIVES; DESIGN; MOIETY;
D O I：
10.12955/cbup.v6.1268
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Acetylcholinesterase (AChE) is a good target in the design of new drugs for the treatment of Alzheimer's disease. The currently known drugs-donepezil, galantamine and rivastignime- act as moderate AChE inhibitors. In the present study, we docked a newly synthesized arylpiperazine derivative 1-(3-(4-benzylpiperazin-1-yl)propyl)-3,7-dimethyl-1H-purine-2,6(3H,7H)-dione (LA1) into rhAChE and identified its binding mode. The docking pose of the studied LA1 molecule depends of the protonated state of the nitrogen atom of the piperazine moiety where in the best scored poses, the xanthine moiety of LA1 is bound into the catalytic active site (CAS) of AChE, while the arylpiperazine fragment is placed into the peripheral binding site (PAS). The Ellman's test confirmed the compound binding. LA1 has good permeability through the GIT and BBB assessed by PAMPA. LA1 is a prospective lead for AChE inhibition.
引用
收藏
页码：898 / 903
页数：6
相关论文
共 50 条
  • [41] Molecular docking study and anticonvulsant activity of synthesized 4-((4,6-dimethyl-6H-1, 3-thiazin-2-yl)phenylsulfonyl)urea/thiourea derivatives
    Thakur, Alok Singh
    Deshmukh, Ravitas
    Jha, Arvind Kumar
    Kumar, P. Sudhir
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2018, 30 (03) : 330 - 336
  • [42] (2R, 4S, 5S) 1-(4-(4-(((7-Chloroquinolin-4-yl)amino)methyl)-1H-1,2,3-triazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
    Kuan, Houin
    Xie, Yuhan
    Guo, Yuzhu
    Gianoncelli, Alessandra
    Ribaudo, Giovanni
    Coghi, Paolo
    MOLBANK, 2023, 2023 (03)
  • [43] Synthesis and some reactions of novel (4Z)-4-{[1-(3-chlorophenyl)-3-(4-methoxyphenyl)-1H-pyrazol-4-yl]methylene}-2-hydrazinyl-1-phenyl-1H-imidazol-5(4H)-ones
    Khalifa, N. M.
    Al-Omar, M. A.
    Nossier, E. S.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2017, 87 (07) : 1621 - 1626
  • [44] Design, Synthesis, and Molecular Docking Study of 6-Aryl-3-(quinolin-3-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thia­diazines as Novel Antimicrobial Agents
    N. M. Mallisetty
    T. R. Allaka
    H. Ganipisetti
    D. Majhi
    R. Sirisilla
    V. N. K. Putta
    Russian Journal of Organic Chemistry, 2022, 58 : 1851 - 1860
  • [45] 3-(4-Ferrocenyl-1H-1,2,3-triazol-1-yl)cholic Acid
    D'Annibale, Valeria
    Raglione, Venanzio
    Lisi, Francesco
    Verdirosi, Elisa
    Romagnoli, Lorenza
    Dini, Danilo
    Galantini, Luciano
    D'Annibale, Andrea
    MOLBANK, 2024, 2024 (04)
  • [46] The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties
    Siu, Tony
    Brubaker, Jason
    Fuller, Peter
    Torres, Luis
    Zeng, Hongbo
    Close, Joshua
    Mampreian, Dawn M.
    Shi, Feng
    Liu, Duan
    Fradera, Xavier
    Johnson, Kevin
    Bays, Nathan
    Kadic, Elma
    He, Fang
    Goldenblatt, Peter
    Shaffer, Lynse
    Patel, San Ita B.
    Lesburg, Charles A.
    Alpert, Carla
    Dorosh, Lauren
    Deshmukh, Sujal V.
    Yu, Hongshi
    Klappenbach, Joel
    Elwood, Fiona
    Dinsmore, Christopher J.
    Fernandez, Rafael
    Moy, Lily
    Young, Jonathan R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9676 - 9690
  • [47] Ultrasound-assisted synthesis of novel Schiff bases from 3-(2-oxo-2H-chromen-3-yl)-1-(4-phenylthiazol-2-yl)-1H-pyrazole-4-carboxaldehyde and their cytotoxicity, apoptosis, cell cycle, molecular docking, and ADMET profiling
    Assiri, Mohammed A.
    Ali, Tarik E.
    Alsolimani, Ayat K.
    Shati, Ali A.
    Alfaifi, Mohammad Y.
    Elbehairi, Serag E. I.
    SYNTHETIC COMMUNICATIONS, 2024, 54 (11) : 881 - 908
  • [48] Molecular Docking, Spectroscopic, and Computational Studies of 2-{3-(4-Chlorophenyl)-5-[4-(Propan-2-yl) Phenyl]-4, 5-Dihydro-1H-Pyrazol-1-yl}-1, 3-Thiazol-4(5H)-One
    Jayasudha, J.
    Balachandran, V.
    Narayana, B.
    POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42 (05) : 2222 - 2244
  • [49] 3-(5-(1H-imidazol-1-yl) pent-1-en-1-yl)-9-ethyl-9H-carbazole: synthesis, characterization (IR, NMR), DFT, antimicrobial-antioxidant activities and docking study
    Unver, Yasemin
    Suleymanoglu, Nevin
    Ustabas, Resat
    Bektas, Kadriye Inan
    Bektas, Ersan
    Guler, Halil Ibrahim
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23) : 12990 - 13000
  • [50] Interdisciplinary insights into (1′R,3S,3′R)-1'-(4-chlorobenzoyl)-5′,6′,7′,7a′-tetrahydro-1′H ′ R,3S,3 ′ R)-1'-(4-chlorobenzoyl)-5 ′,6 ′,7 ′,7a ′-tetrahydro-1 ′ H dispiro [indoline-3,2′-pyrrolizine-3′,3"-indoline]-2,2"-dione: ′-pyrrolizine-3 ′,3 "-indoline]-2,2 "-dione: Structural, electronic , and molecular dynamics perspectives
    Jose, Jisna
    Varughese, Jibin K.
    Ali, Nemat
    Alasmari, Abdullah F.
    Ansari, Mushtaq Ahmad
    Patil, Sandip
    Mathew, Thomas, V
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2024, 101 (10)
12345